The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.

Oncogene · 2019 · PMC6755966 · PMID 31253868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

TMED9 quintiles showed a trend where top expressors showed poorer outcomes, but these did not reach significance of p = 0.05 (Supplemental Fig. 13 ), much as reported for TMED3 [ 8 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.